Increasing Prevalence of Diseases Worldwide to Augment the Patent Medicine Market Growth

Patent Medicine Market


 Patent medicine is a pharmaceutical product developed for the first time for a specific disease condition. Only a company that holds the patent of a particular medicine is allowed to manufacture it and make a profit. Sometimes, pharmaceutical companies are granted drug patents for 20 years. Sometimes the duration of a patent for a drug varies in years according to its usefulness and the country in which the patent is applied for approval. The effective duration is mostly seven to twelve years.

Market Dynamics:

Increasing prevalence of diseases worldwide is expected to propel the growth of the patent medicine market. Hundreds of drug patents are launched every year. For instance, in February 2021, Pfizer Inc. announced that the U.S. Patent and Trademark Office (USPTO) recently issued a U.S. Patent Term Extension (PTE) certificate for IBRANCE (palbociclib). The PTE certificate was granted under the patent restoration provisions of the Drug Price Competition and Patent Term Restoration Act of 1984.

Moreover, in February 2021, PolarityTE announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application No. 16/165,169 filed on October 19, 2018. This is the Company’s second patent allowance in the United States.

Furthermore, increasing research and development activities by key players in the market for novel medicines, especially in North America, is expected to augment the growth of the patent medicine market. For instance, in July 2020, Pfizer patented its substituted carbonucleoside derivatives useful as anticancer agents.

The emergence of COVID-19 is expected to offer lucrative growth opportunities for players in the patent medicine market. For instance, in February 2021, IncellDx filed patents for algorithms identifying immunologic profiles unique to COVID long haulers and patients with severe COVID. However, the high cost of patent medicine compared to generic medicine is expected to restrain the patent medicine market growth.

Competitive Analysis:

Major players operating in the patent medicine market are AbbVie Inc, Amgen Inc, Roche Holding AG, Merck & Co., Inc., Sanofi S.A, Novartis International AG, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer Inc.

In June 2020, GlaxoSmithKline patented invention related to immunogenic compositions such as vaccines, comprising immunogenic polypeptides from Haemophilus influenzae and Moraxella catarrhalis, which is used for boosting immune response.

In April 2020, Otsuka Pharmaceutical patented invention related to an injectable preparation comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt, which has a wide therapeutic spectrum for central nervous system diseases (particularly schizophrenia).

Comments

Post a Comment

Popular posts from this blog

Bourbon Whiskey Is the Most Popular Whiskey in America and In Many Other Countries around the World

Image
  Whiskey or single malt whiskey is simply a form of distilled beverage made by distilling alcohol from grain mash or even by blending both. Different grains are utilized for different types, such as corn, barley, rye, and wheat. In Scotland, they call their whiskey black tea, a lighter caramel scotch, Irish cream, and liqueur. Whichever form is utilized, the result is usually a flavorful and smooth drink that has a distinct taste, and many people prefer a whiskey with a lower alcohol content. For example, single malt whiskey is the least expensive. The highest price however is the least distilled; that is Bourbon whiskey. Bourbon whiskey is the most popular whiskey in America and in many other countries around the world. Its price range is very wide, starting from as low as about US$ 12 a bottle to over a hundred dollars. So the price definitely varies. Whichever class you belong to, there is always a whiskey that will suit your preference. Single malt scotch whiskey is made ...
Read more

Viral Vectors And Plasmid DNA Manufacturing Market Is Gaining Major Traction With Oxford Biomedica Plc Entering Into A 3-Year Agreement With Boehringer Ingelheim For The Manufacture And Supply Of Various Types Of Viral Vectors

Image
  Viral Vectors are proteins that have been discovered to be essential for the spread of various viruses and infectious agents. These proteins can cause serious health risks if they are improperly introduced or if a wrong agent is used to fight them off. Viral vectors have often been used in various gene therapy procedures with the ultimate objective of curing various ailments in the biological fields of neurology, gene therapy, cancer, and metabolic disorder. Clinical studies regarding viral vectors remain one of the key factors in the manufacturing of viral vectors. Plasmids are used to deliver DNA contain genes for antibiotic resistance. In fact, scientists have developed many uses of plasmids and created software to record the DNA sequences of plasmids for applications in various techniques. Thus, such continuous R&D activities can potentially stimulate growth of the viral vectors and plasmid DNA manufacturing market . Recently, in April 2021, Oxford Biomedica plc entered...
Read more

Hard Surface Flooring Market Is Expected To Witness Robust Growth As Mohawk Industries Introduces Newly Imagined 30,000-Square Foot Floor Space At The International Surface Event (TISE)

Image
  There are many reasons why people choose hard surface floors over other types of flooring. Hard surfaces offer a level of durability and are very aesthetically pleasing. Unfortunately, choosing this type of flooring can be confusing and costly. There are four main hard surface varieties namely vinyl plank, laminate, solid hardwood, and engineered wood. Each has their own style strengths and provide different advantages. Increasing population coupled with rapid urbanization is expected to drive growth of the global hard surface flooring market . According to the United Nations (UN), by 2050, around 68% of the global population is expected to live in urban areas, increasing from 55% in 2018. According to the same source, in 2018, around 4.2 billion people were living in urban areas, increasing from 751 million in 1950. Furthermore, according to the World Bank, in 2019, the global population reached 7.674 billion, increasing from 6.84 billion in 2009. As a result of this, building...
Read more